Aaron M Samuels
Overview
Explore the profile of Aaron M Samuels including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamau A, Obiet K, Ogwang C, McDermott D, Lesosky M, Janssen J, et al.
Malar J
. 2025 Mar;
24(1):69.
PMID: 40033279
No abstract available.
2.
Kamau A, Obiet K, Ogwang C, McDermott D, Lesosky M, Janssen J, et al.
Malar J
. 2024 Dec;
23(1):403.
PMID: 39736740
Background: In western Kenya, a cluster-randomized trial is assessing the impact of attractive targeted sugar baits (ATSBs) on malaria in children enrolled in three consecutive cohorts. Here, characteristics of children...
3.
Cohen C, du Plessis M, Martinson N, Moyes J, Walaza S, Wolter N, et al.
J Infect Dis
. 2024 Nov;
231(2):e328-e336.
PMID: 39542652
Background: Approaches for determining whether influenza vaccination prevents infection, attenuates illness, or both are important for developing improved vaccines. We estimated influenza infection incidence and evaluated symptom ascertainment methodologies in...
4.
Chiwandire N, Walaza S, von Gottberg A, Wolter N, du Plessis M, Moosa F, et al.
Int J Epidemiol
. 2024 Sep;
53(5).
PMID: 39305220
Background: COVID-19 vaccine effectiveness (VE) studies leveraging systematic surveillance in sub-Saharan Africa are limited. We assessed the effectiveness of two vaccines (Pfizer BNT162b2 and Johnson & Johnson Ad26.COV2.S) against SARS-CoV-2-associated...
5.
Verani J, Eno E, Hunsperger E, Munyua P, Osoro E, Marwanga D, et al.
PLoS One
. 2024 Aug;
19(8):e0305700.
PMID: 39088453
Acute febrile illness (AFI) is a common reason for healthcare seeking and hospitalization in Sub-Saharan Africa and is often presumed to be malaria. However, a broad range of pathogens cause...
6.
Juraska M, Early A, Li L, Schaffner S, Lievens M, Khorgade A, et al.
Lancet Infect Dis
. 2024 May;
24(9):1025-1036.
PMID: 38723650
Background: The first licensed malaria vaccine, RTS,S/AS01, confers moderate protection against symptomatic disease. Because many malaria infections are asymptomatic, we conducted a large-scale longitudinal parasite genotyping study of samples from...
7.
Bishop K, Meiring S, Tempia S, von Gottberg A, Wolter N, Kleynhans J, et al.
Influenza Other Respir Viruses
. 2024 Apr;
18(5):e13300.
PMID: 38666359
Background: Identifying children at risk for severe COVID-19 disease from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may guide future mitigation interventions. Using sentinel surveillance data, we aimed to identify...
8.
Asante K, Mathanga D, Milligan P, Akech S, Oduro A, Mwapasa V, et al.
Lancet
. 2024 Apr;
403(10437):1660-1670.
PMID: 38583454
Background: The RTS,S/AS01 malaria vaccine (RTS,S) was introduced by national immunisation programmes in Ghana, Kenya, and Malawi in 2019 in large-scale pilot schemes. We aimed to address questions about feasibility...
9.
Westercamp N, Osei-Tutu L, Schuerman L, Kariuki S, Bollaerts A, Lee C, et al.
J Infect Dis
. 2024 Mar;
230(2):e486-e495.
PMID: 38438123
Background: The RTS,S/AS01E (RTS,S) malaria vaccine is recommended for children in malaria endemic areas. This phase 2b trial evaluates RTS,S fractional- and full-dose regimens in Ghana and Kenya. Methods: In...
10.
Ogbuanu I, Otieno K, Varo R, Sow S, Ojulong J, Duduyemi B, et al.
J Infect
. 2024 Jan;
88(3):106107.
PMID: 38290664
Background: Malaria is a leading cause of childhood mortality worldwide. However, accurate estimates of malaria prevalence and causality among patients who die at the country level are lacking due to...